Mir A Imran bought $1.3M of RANI
director, owner at Rani Therapeutics Holdings, Inc.. 2,083,334 shares at an average of $0.61, traded Oct 23, 2025, filed Oct 27, 2025.
Score components
- +15RoleDirector
- +25Trade size$1.3M at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- +4Price context27% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001031686-25-000004, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 23, 2025 | POpen-market purchase Class A Common Stock | +2,083,334 | $0.61 | $1.3M | 2,083,334 | Oct 27, 2025 |
| Oct 23, 2025 | POpen-market purchase Warrant to Purchase Class A Common Stockderivative | +2,083,334 | $0.00 | $0 | 2,083,334 | Oct 27, 2025 |
Related signals
Other insiders at Rani Therapeutics Holdings, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 57Moderate | RANIsell Rani Therapeutics Holdings, Inc. | South Cone Investments Limited Partnership owner | $16M 5,923,000 shares | -71% | |
| 36Weak | Rani Therapeutics Holdings, Inc. | Kate McKinley Chief Business Officer | $30k 17,960 shares | - | |
| 33Weak | Rani Therapeutics Holdings, Inc. | Talat Imran Chief Executive Officer | $20k 10,296 shares | +2% | |
| 47Moderate | RANIsell Rani Therapeutics Holdings, Inc. | South Cone Investments Limited Partnership owner | $10M 3,829,360 shares | -32% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.